Methylphenidate for Attention Problems After Pediatric TBI
Efficacy of Methylphenidate for Management of Long-Term Attention Problems After Pediatric Traumatic Brain Injury (TBI)
Sponsor: Children's Hospital Medical Center, Cincinnati
Listed as NCT01933217, this PHASE4 trial focuses on ADHD and TBI and remains completed. Sponsored by Children's Hospital Medical Center, Cincinnati, it has been updated 8 times since 2013, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Feb 2020 — Jul 2020 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
▶ Show 3 earlier versions
-
Dec 2018 — Feb 2020 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Medical Center, Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .